Intensive Care Unit, Royal Liverpool University Hospital
Liverpool, L7 8XP, United Kingdom
NCT Number: NCT03770442
Muscle wasting is a common consequence of critical illness, and has a profound impact upon the rehabilitation of those who survive admission to critical to care. The investigators intend to assess if the application of 10 sessions over two weeks of passive cycling with electrical stimulation to the lower limbs and abdomen can prevent muscle loss, or at least cause less muscle loss, compared to patients who receive standard daily sessions of physiotherapy. This will be done by comparing the changes in muscle size on ultrasound between the two groups, comparing functional measures at a 3 month follow up, and by performing translational research using tissue samples taken during the study.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Liverpool, L7 8XP, United Kingdom
Patients are mechanically ventilated and sedated with a diagnosis of sepsis (from any source) will be eligible for this study. Provided they meet the inclusion criteria, they will be randomised within 48 hours of admission, to either ten 30 minute sessions of passive cycling with functional electrical stimulation (FES) to the thighs, hamstrings, calves and abdomen over a 14 day period, or to a control group of routine physiotherapy. The trial group will also receive this physiotherapy.
On admission to the study, all patients will receive on day 1:
Ultrasound measurements of:
Rectus femoris cross-sectional area Thickness of rectus femoris and vastus intermedius Thickness, pennation angle and derived fascicle length of vastus lateralis and medial head of gastrocnemius Thickness of rectus abdominis. Thickness of diaphragm
A blood sample taken from an arterial line A urine sample taken from a urinary catheter A muscle biopsy taken from the right vastus lateralis
They will then receive ten 30 minute sessions of passive cycling with functional electrical stimulation over 14 days, or a control group will receive routine physiotherapy during this period.
Repeat ultrasounds will be taken at days 3, 5, 7, 10 and 14. Repeat blood and urine sampling at days 5, 10 and 14. Repeat muscle biopsy at day 14.
All cycling, ultrasounds and tissue sampling will end on day 14 regardless of the ventilator status of the patient.
In patients who survive to be discharged from critical care, they will be followed up at 3 months for:
Repeat ultrasound scan of all muscles listed Six minute walk test Hand grip and lower limb dynamometry, Balance testing (by standing upright on a pressure plate for 20 seconds) Psychological assessment using the 36 item Short Form (SF-36) questionnaire
Tissue sampling will be stored in the University of Liverpool for analysis of biomarkers of muscle damage and loss between the two groups.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Sepsis has been recently redefined as: "Life threatening organ-dysfunction caused by dysregulated host response to infection" whilst septic shock has become a subset of sepsis, defined as: "circulatory and cellular/metabolic dysfunction associated with a higher risk of mortality(44).
For the purposes of this study, a patient will be regarded as septic if they have evidence of infection-related organ failure (e.g. sepsis-associated coagulopathy, altered mental state, cardiovascular dysfunction, acute kidney injury, and altered liver function) and require invasive mechanical ventilation with either definite or suspected evidence of infection. This is to allow prompt treatment with FES rather than waiting for a positive microbiological result to be obtained.
Within the definition of sepsis "from any source" a list of following is illustrative but not exhaustive:
Exclusion criteria
As described already
Other names: RT-300 Supine, Restorative Therapies
As described already
Time frame: Ultrasounds taken on day 1, 3, 5, 7, 10 and 14, and at 3 month follow up.
Measurement of cross-sectional area of rectus femoris (cm2)
Time frame: Ultrasounds taken on day 1, 3, 5, 7, 10 and 14, and at 3 month follow up.
Measurement on muscle layer thickness of rectus femoris (cm)
Time frame: Ultrasounds taken on day 1, 3, 5, 7, 10 and 14, and at 3 month follow up.
Measurement of combined muscle layer thickness of rectus femoris and vastus intermedius (cm)
Time frame: Ultrasounds taken on day 1, 3, 5, 7, 10 and 14, and at 3 month follow up.
Measurement of the thickness of the vastus lateralis between the superficial and deep aponeuroses (cm)
Time frame: Ultrasounds taken on day 1, 3, 5, 7, 10 and 14, and at 3 month follow up.
Measurement of the pennation angle of the muscle fascicles as they insert into the deep aponeuroses of the vastus lateralis muscle (degrees)
Time frame: Ultrasounds taken on day 1, 3, 5, 7, 10 and 14, and at 3 month follow up.
This is a single measure, derived by trigonometry (the Sine of the pennation angle multiplied by the muscle thickness).
Time frame: Ultrasounds taken on day 1, 3, 5, 7, 10 and 14, and at 3 month follow up.
Measurement of the thickness of the medial head of the gastrocnemius between the superficial and deep aponeuroses (cm)
Time frame: Ultrasounds taken on day 1, 3, 5, 7, 10 and 14, and at 3 month follow up.
Measurement of the pennation angle of the muscle fascicles as they insert into the deep aponeuroses of the medial head of gastrocnemius (angles)
Time frame: Ultrasounds taken on day 1, 3, 5, 7, 10 and 14, and at 3 month follow up.
This is single measure which is mathematically derived by trigonometry using the known pennation angle (degrees) and thickness (cm): the Sine of the pennation angle multiplied by the muscle thickness.
Time frame: Ultrasounds taken on day 1, 3, 5, 7, 10 and 14, and at 3 month follow up.
Measurement of rectus abdominis muscle layer thickness - (cm)
Time frame: Ultrasounds taken on day 1, 3, 5, 7, 10 and 14, and at 3 month follow up.
Assessment of thickness at end expiration (mm)
Time frame: Ultrasounds taken on day 1, 3, 5, 7, 10 and 14, and at 3 month follow up.
Assessment of thickness at end inspiration (mm)
Time frame: Ultrasounds taken on day 1, 3, 5, 7, 10 and 14, and at 3 month follow up.
Assessment of thickening fraction, derived mathematically from thicknesses at inspiration and expiration (%)
Time frame: Ultrasounds taken on day 1, 3, 5, 7, 10 and 14, and at 3 month follow up.
Assessment of maximal excursion of diaphragm, measured with M-mode ultrasonography (mm)
Time frame: Samples taken on days 1, 5, 10 and 14
Blood samples taken during the study period and analysed for markers of muscle loss/degradation
Time frame: Samples taken on days 1, 5, 10 and 14
Blood and urine samples taken during the study period and analysed for markers of muscle loss/degradation
Time frame: Samples taken on day 1 and 14
Muscle biopsy samples taken during the study period and analysed for markers of muscle loss/degradation. Number and type of micro-RNAs to be noted).
Time frame: Samples taken on day 1 and 14
Histological staining and analysis of muscle fibre composition, expressed in square millimetres and as a percentage-fold increase/decrease compared to baseline).
Time frame: At 3 month follow up
Distance achieved during a 6 minute shuttle walk of 20 metres length
Time frame: At 3 month follow up
Strength of hand grip in both hands
Time frame: At 3 month follow up
Strength of extension at the knee in both legs using a hand held dynamometry device (microFET 2 wireless device). Measured in Newtons.
Time frame: At 3 month follow up
Comparison of changes in centre of pressure on a pressure plate. The centre of pressure is measured over 20 seconds with the participant standing still. Maximal variation in lateral and anterior-posterior sway is recorded by the pressure plate.
Time frame: At 3 month follow up
Comparison of scores obtained from the SF-36 questionnaire between the two groups. A lower score indicates greater disability.
Time frame: At 3 month follow up
Using the Power Breathe K2 device
Time frame: Days 1-14
Assessed by twice daily Cambridge Assessment Method for the ICU (CAM-ICU) assessments
Time frame: Days 1-14
Daily monitoring to see if patient has required renal replacement therapy (defined as either haemofiltration or haemodialysis).
Time frame: Day 1-14
Daily monitoring of doses of inotropic and vasopressor drugs
Time frame: Day 1-14
Daily noting of 24 hour fluid balance
Time frame: Day 1-14
Daily monitoring of exogenous insulin requirements
Time frame: Day 1-14
Daily monitoring of glucose levels
Time frame: Days 1 - 14 but only on the days where cycling takes place (ten sessions)
Measured via a wireless skin patch
Time frame: Days 1 - 14 but only on the days where cycling takes place (ten sessions)
Expressed as a simple count of how many times an airway device dislodges
Time frame: Days 1 - 14 but only on the days where cycling takes place (ten sessions).
Expressed as a simple count of how many times a nasogastric feed tube dislodges.
Time frame: Days 1 - 14 but only on the days where cycling takes place (ten sessions).
Expressed as a simple count of how many times a central or arterial line dislodges.
University of Liverpool
Other
Effect of Early Rehabilitation Using an Active/Passive Cycling Device on Muscle Wasting in the Critically Ill: A Randomised Controlled Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05956964
Mental Disorders, Muscle Weakness
Lexington, Kentucky, United States
View Trial DetailsNCT06216015
Chronic Disease, Chronic Kidney Failure
View Trial DetailsNCT07555782
Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
Ataşehir, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07590557
Burn Injury, Burns
Al Kharj, Saudi Arabia
View Trial Details